Siemens Medical Solutions USA, Inc. and Consolidated Subsidiaries

CourtUnited States Tax Court
DecidedJuly 15, 2026
Docket11432-25
StatusPublished

This text of Siemens Medical Solutions USA, Inc. and Consolidated Subsidiaries (Siemens Medical Solutions USA, Inc. and Consolidated Subsidiaries) is published on Counsel Stack Legal Research, covering United States Tax Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Siemens Medical Solutions USA, Inc. and Consolidated Subsidiaries, (tax 2026).

Opinion

United States Tax Court REVIEWED 167 T.C. No. 5

SIEMENS MEDICAL SOLUTIONS USA, INC. AND CONSOLIDATED SUBSIDIARIES, Petitioner

v.

COMMISSIONER OF INTERNAL REVENUE, Respondent

—————

Docket No. 11432-25. Filed July 15, 2026.

I.R.C. § 245A, which was enacted by the Tax Cuts and Jobs Act (TCJA), Pub. L. No. 115-97, § 14101, 131 Stat. 2054, 2189 (2017), provides a deduction (DRD) for certain dividends received by a U.S. corporation from certain foreign corporations. The DRD applies to distributions made after December 31, 2017.

The TCJA included interrelated provisions to move the U.S. tax system from a worldwide tax system to a territorial tax system. The provisions did not all have the same effective dates and created gaps that affect certain taxpayers. The Department of the Treasury and the IRS issued Temp. Treas. Reg. § 1.245A-5T, which limits the DRD under I.R.C. § 245A to address one such gap.

P claimed the full DRD under I.R.C. § 245A for a dividend received from a foreign source. In its Motion for Summary Judgment, P argues that it is entitled to a DRD for the full amount and that the limitation provided in the temporary regulation does not apply. In R’s Cross-Motion for Summary Judgment, R argues that the temporary regulation does apply and that P is entitled to a limited DRD.

Served 07/15/26 2

Held: P is entitled to the full DRD under I.R.C. § 245A.

Held, further, Temp. Treas. Reg. § 1.245A-5T does not alter this conclusion because it cannot contravene the clear statutory text.

KERRIGAN, J., wrote the opinion of the Court, which URDA, C.J., and BUCH, NEGA, PUGH, ASHFORD, COPELAND, JONES, TORO, GREAVES, MARSHALL, WEILER, WAY, LANDY, ARBEIT, GUIDER, and FUNG, JJ., joined.

JENKINS, J., did not participate in the consideration of this opinion.

Eric J. Konopka, Jean Ann Pawlow, and Alexandra B. Clionsky Kelly, for petitioner.

Nicholas D. Doukas, William Tyler Halasz, Laura A. Humphreys, and Victor W. Zhao, for respondent.

OPINION

KERRIGAN, Judge: This case is before the Court on petitioner’s Motion for Summary Judgment (Motion) and respondent’s Cross-Motion for Summary Judgment (Cross-Motion). Respondent issued a Notice of Deficiency for tax year ended September 30, 2019 (2019 Tax Year), and tax year ended September 30, 2021 (2021 Tax Year), disallowing a full deduction pursuant to section 245A1 and accompanying regulations for the 2019 Tax Year. 2 Respondent determined that petitioner is entitled to a partial section 245A deduction because of the application of the

1 Unless otherwise indicated, statutory references are to the Internal Revenue

Code, Title 26 U.S.C. (Code), in effect at all relevant times, regulation references are to the Code of Federal Regulations, Title 26 (Treas. Reg.), in effect at all relevant times, and Rule references are to the Tax Court Rules of Practice and Procedure. 2 The partial disallowance of the section 245A deduction resulted in a series of

adjustments for the 2021 Tax Year. 3

Extraordinary Disposition Rules, which are part of the section 245A temporary regulations. See T.D. 9865, 2019-27 I.R.B. 27, 30.

In its Motion petitioner moves for summary judgment because the deficiencies that respondent determined rest on the application of a regulation that petitioner contends is invalid as a matter of law. Respondent seeks summary adjudication that the Extraordinary Disposition Rules are valid.

For the reasons discussed below, we hold that the Extraordinary Disposition Rules cannot contravene the plain meaning of section 245A. Accordingly, we will grant petitioner’s Motion and deny respondent’s Cross-Motion.

Background

The facts set out are derived from the parties’ pleadings and Motion papers. See Rule 121(c)(1). They are stated solely for the purpose of deciding the pending Motion and are not findings of fact for this case. See Sundstrand Corp. v. Commissioner, 98 T.C. 518, 520 (1992), aff’d, 17 F.3d 965 (7th Cir. 1994).

Petitioner, Siemens Medical Solutions USA, Inc., is a wholly owned subsidiary of Siemens Healthineers AG (SHAG), a German company that provides healthcare products globally. Its principal place of business was Pennsylvania when its Petition was timely filed. At all relevant times, Siemens Healthcare Diagnostics, Inc. (SHD US), a California corporation and member of petitioner’s U.S. consolidated group, owned 67.78% of Siemens Medical Solutions Diagnostics Holding I.B.V. (SMS BVI), a Dutch company treated as a corporation for U.S. federal income tax purposes.

During the tax year ended September 30, 2018 (2018 Tax Year), certain foreign subsidiaries of SMS BVI were restructured. On April 1, 2018, SMS BVI sold 100% of Siemens Healthcare Diagnostics GmbH, a Swiss company, for €85,715,399 to Siemens Healthineers Holding III BV, a Dutch company within the SHAG Group (SHAG and its subsidiaries).

On August 13, 2018, SMS BVI sold 100% of Siemens Healthcare Diagnostics Holding GmbH, a German company, to Siemens Healthcare GmbH, a German company within the SHAG Group, for €1,339,593,000. As a result of these two sales, SMS BVI increased its earnings and profits (E&P) by approximately €819,000,000. 4

On March 19, 2019, SMS BVI made a pro rata distribution of €1,750,000,000 to its shareholders (March 2019 Distribution). Since SHD US owned 67.78% of SMS BVI, it received 67.78% of the March 2019 Distribution which was €1,186,073,740. Of that amount $670,616,109 was a dividend made out of SMS BVI’s E&P (March 2019 Dividend). The March 2019 Dividend was entirely foreign source.

Petitioner timely filed consolidated federal income tax returns for its 2019 Tax Year and its 2021 Tax Year. On its Form 1120, U.S. Corporation Income Tax Return, for its 2019 Tax Year, petitioner claimed a deduction for the full amount of the March 2019 Dividend. When preparing its tax return for the 2019 Tax Year, petitioner considered the implications of the Extraordinary Disposition Rules, and it concluded that its two sales that occurred in 2018 “likely” fit the definition of “extraordinary dispositions” under those rules. Of the March 2019 Dividend, $40,630,184 was not attributable to the two sales occurring in 2018. If the Extraordinary Disposition Rules apply, a deduction for $314,992,962 of the March 2019 Dividend would be disallowed.

Petitioner concluded that the Extraordinary Disposition Rules were invalid and that it was entitled to the full section 245A deduction. It filed Form 8275–R, Regulation Disclosure Statement, with its tax return for its 2019 Tax Year. On its Form 8275–R, petitioner disclosed the relevant facts and its legal analysis supporting its position that the Extraordinary Disposition Rules are invalid.

In the Notice of Deficiency respondent determined deficiencies of $5,581,518 and $1,452,006 for the 2019 Tax Year and the 2021 Tax Year, respectively. Respondent disallowed $314,992,962 of the section 245A deduction.

Discussion

I. Summary Judgment

The purpose of summary judgment is to expedite litigation and avoid costly, time-consuming, and unnecessary trials. Fla. Peach Corp. v. Commissioner, 90 T.C. 678, 681 (1988). Under Rule 121(a), either party may move for summary judgment regarding all or any part of the legal issues in controversy. We may grant summary judgment only if there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law. Rule 121(a)(2); Sundstrand Corp., 98 T.C. at 520. The moving party bears the burden of 5

demonstrating that there is no genuine dispute as to any material fact. FPL Grp., Inc. & Subs. v. Commissioner, 116 T.C. 73, 74–75 (2001).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cook v. Tait
265 U.S. 47 (Supreme Court, 1924)
Davis v. Michigan Department of the Treasury
489 U.S. 803 (Supreme Court, 1989)
Connecticut National Bank v. Germain
503 U.S. 249 (Supreme Court, 1992)
Michigan v. EPA
576 U.S. 743 (Supreme Court, 2015)
In Re the Complaint of Nautilus Motor Tanker Co.
85 F.3d 105 (Third Circuit, 1996)
Wisconsin Central Ltd. v. United States
585 U.S. 274 (Supreme Court, 2018)
Pereira v. Sessions
585 U.S. 198 (Supreme Court, 2018)
Huff v. Commissioner
135 T.C. No. 10 (U.S. Tax Court, 2010)
FPL Group, Inc. v. Commissioner
116 T.C. No. 7 (U.S. Tax Court, 2001)
Textron Inc. v. Comm'r
117 T.C. No. 7 (U.S. Tax Court, 2001)
Dave Fischbein Mfg. Co. v. Commissioner
59 T.C. 338 (U.S. Tax Court, 1972)
Dougherty v. Commissioner
60 T.C. No. 97 (U.S. Tax Court, 1973)
Florida Peach Corp. v. Commissioner
90 T.C. No. 41 (U.S. Tax Court, 1988)
Sundstrand Corp. v. Commissioner
98 T.C. No. 36 (U.S. Tax Court, 1992)
Monssef Cheneau v. Merrick Garland
997 F.3d 916 (Ninth Circuit, 2021)
Sossamon v. Texas
179 L. Ed. 2d 700 (Supreme Court, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
Siemens Medical Solutions USA, Inc. and Consolidated Subsidiaries, Counsel Stack Legal Research, https://law.counselstack.com/opinion/siemens-medical-solutions-usa-inc-and-consolidated-subsidiaries-tax-2026.